Re: Still waiting for that BETonMACE CKD sub-study 7 months later
in response to
by
posted on
Jun 12, 2020 12:32PM
Two different things, this is for improved treatment of advanced chf, RVX is talking about prevention of CHF. Amgen has spent 500 million on omecamtiv